{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:57:02Z","timestamp":1776412622056,"version":"3.51.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011201","name":"FP7 Science in Society","doi-asserted-by":"publisher","award":["HEALTH-F7-305507 HOMAGE"],"award-info":[{"award-number":["HEALTH-F7-305507 HOMAGE"]}],"id":[{"id":"10.13039\/100011201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00392-022-02116-w","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T11:03:54Z","timestamp":1666609434000},"page":"330-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"John G. F.","family":"Cleland","sequence":"additional","affiliation":[]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[]},{"given":"Mark R.","family":"Hazebroek","sequence":"additional","affiliation":[]},{"given":"Job","family":"Verdonschot","sequence":"additional","affiliation":[]},{"given":"Timothy J.","family":"Collier","sequence":"additional","affiliation":[]},{"given":"Johannes","family":"Petutschnigg","sequence":"additional","affiliation":[]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[]},{"given":"Jan A.","family":"Staessen","sequence":"additional","affiliation":[]},{"given":"Stephane","family":"Heymans","sequence":"additional","affiliation":[]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"2116_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/circheartfailure.113.000792","volume":"7","author":"P Rossignol","year":"2014","unstructured":"Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N et al (2014) Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Circ Heart Fail 7:51\u201358. https:\/\/doi.org\/10.1161\/circheartfailure.113.000792","journal-title":"Circ Heart Fail"},{"key":"2116_CR2","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","volume":"60","author":"O Vardeny","year":"2012","unstructured":"Vardeny O, Wu DH, Desai A, Rossignol P, Zannad F, Pitt B, Solomon SD (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol 60:2082\u20132089. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.048","journal-title":"J Am Coll Cardiol"},{"key":"2116_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jacc.2020.12.057","volume":"77","author":"IE Beldhuis","year":"2021","unstructured":"Beldhuis IE, Myhre PL, Bristow M, Claggett B, Damman K, Fang JC, Fleg JL, McKinlay S, Lewis EF, O\u2019Meara E et al (2021) Spironolactone in patients with heart failure, preserved ejection fraction, and worsening renal function. J Am Coll Cardiol 77:1211\u20131221. https:\/\/doi.org\/10.1016\/j.jacc.2020.12.057","journal-title":"J Am Coll Cardiol"},{"key":"2116_CR4","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/s0140-6736(18)31808-7","volume":"393","author":"P Rossignol","year":"2019","unstructured":"Rossignol P, Hernandez AF, Solomon SD, Zannad F (2019) Heart failure drug treatment. Lancet 393:1034\u20131044. https:\/\/doi.org\/10.1016\/s0140-6736(18)31808-7","journal-title":"Lancet"},{"key":"2116_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa758","author":"JGF Cleland","year":"2020","unstructured":"Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ, Cosmi F, Brunner La Rocca HP et al (2020) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart \u201cOMics\u201d in AGEing (HOMAGE) randomized clinical trial. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa758","journal-title":"Eur Heart J"},{"key":"2116_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1716","author":"P Pellicori","year":"2020","unstructured":"Pellicori P, Ferreira JP, Mariottoni B, Brunner-La Rocca HP, Ahmed FZ, Verdonschot J, Collier T, Cuthbert JJ, Petutschnigg J, Mujaj B et al (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1716","journal-title":"Eur J Heart Fail"},{"key":"2116_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14086","author":"L Monzo","year":"2022","unstructured":"Monzo L, Ferreira JP, Cleland JGF, Pellicori P, Mariottoni B, Hazebroek MR, Collier TJ, Cuthbert JJ, Pieske B, Petutschnigg J et al (2022) Dyskalemia in people at increased risk for heart failure: findings from the heart \u201cOMics\u201d in AGEing (HOMAGE) trial. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.14086","journal-title":"ESC Heart Fail"},{"key":"2116_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.11.010","author":"JP Ferreira","year":"2021","unstructured":"Ferreira JP, Verdonschot J, Wang P, Pizard A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F, Cuthbert J et al (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2020.11.010","journal-title":"JACC Heart Fail"},{"key":"2116_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1159\/000519436","volume":"52","author":"JP Ferreira","year":"2021","unstructured":"Ferreira JP, Rossignol P, Bakris G, Mehta C, White WB, Zannad F (2021) Blood and urine biomarkers predicting worsening kidney function in patients with Type 2 diabetes post-acute coronary syndrome: an analysis from the EXAMINE trial. Am J Nephrol 52:969\u2013976. https:\/\/doi.org\/10.1159\/000519436","journal-title":"Am J Nephrol"},{"key":"2116_CR10","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/circulationaha.117.030112","volume":"137","author":"T Ahmad","year":"2018","unstructured":"Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, Felker GM, Hernandez AF, O\u2019Connor CM, Sabbisetti VS et al (2018) Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation 137:2016\u20132028. https:\/\/doi.org\/10.1161\/circulationaha.117.030112","journal-title":"Circulation"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02116-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02116-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02116-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T13:07:22Z","timestamp":1675429642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02116-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2116"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02116-w","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant conflicts of interest to disclose regarding the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by all relevant ethics committees and regulatory bodies. All participants provided written informed consent prior to study specific procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"There is no data of individual persons included in the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}